Cargando…

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease

BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regaden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kero, Tanja, Saraste, Antti, Lagerqvist, Bo, Sörensen, Jens, Pikkarainen, Essi, Lubberink, Mark, Knuuti, Juhani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873130/ https://www.ncbi.nlm.nih.gov/pubmed/34386859 http://dx.doi.org/10.1007/s12350-021-02731-6

Ejemplares similares

Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets
por: Saraste, Antti, et al.
Publicado: (2023)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Prognostic value of combined coronary CT angiography and myocardial perfusion imaging in women and men
por: Kujala, Iida, et al.
Publicado: (2023)

ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging
por: Saraste, Antti, et al.
Publicado: (2020)

Quantitative myocardial blood flow imaging with integrated time-of-flight PET-MR
por: Kero, Tanja, et al.
Publicado: (2017)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

A retrospective evaluation of Bayesian-penalized likelihood reconstruction for [(15)O]H(2)O myocardial perfusion imaging
por: Siekkinen, Reetta, et al.
Publicado: (2023)

Correction to: A retrospective evaluation of Bayesian-penalized likelihood reconstruction for [(15)O]H(2)O myocardial perfusion imaging
por: Siekkinen, Reetta, et al.
Publicado: (2023)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Classification of ischemia from myocardial polar maps in (15)O–H(2)O cardiac perfusion imaging using a convolutional neural network
por: Teuho, Jarmo, et al.
Publicado: (2022)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging
por: Sciagrà, Roberto, et al.
Publicado: (2020)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Influence of image reconstruction on quantitative cardiac (15)O-water positron emission tomography
por: Nordström, Jonny, et al.
Publicado: (2022)

Speckle-tracking echocardiography for predicting improvement of myocardial contractile function after revascularization: a meta-analysis of prospective trials
por: Ballo, Haitham, et al.
Publicado: (2022)

Influence of patient motion on quantitative accuracy in cardiac (15)O-water positron emission tomography
por: Nordström, Jonny, et al.
Publicado: (2021)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Evaluation of quantitative CMR perfusion imaging by comparison with simultaneous (15)O-water-PET
por: Kero, Tanja, et al.
Publicado: (2019)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Effect of PET-CT misalignment on the quantitative accuracy of cardiac (15)O-water PET
por: Nordström, Jonny, et al.
Publicado: (2020)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

(68)Ga-DOTA chelate, a novel imaging agent for assessment of myocardial perfusion and infarction detection in a rodent model
por: Autio, Anu, et al.
Publicado: (2019)

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison
por: Gibarti, Claudia, et al.
Publicado: (2023)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Relation between quantitative coronary CTA and myocardial ischemia by adenosine stress myocardial CT perfusion
por: van Rosendael, Alexander R., et al.
Publicado: (2016)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Assessment of myocardial viability with [(15)O]water PET: A validation study in experimental myocardial infarction
por: Grönman, Maria, et al.
Publicado: (2019)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bbq7a51eqq7apuh9kotnmaq3uh